SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-17-000002
Filing Date
2017-01-06
Accepted
2017-01-06 08:06:19
Documents
47
Period of Report
2017-01-06
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a8k-january2017investorpre.htm 8-K 23009
2 INVESTOR PRESENTATION a2017investorpresentatio.htm EX-99.1 37515
3 a2017investorpresentatio001.jpg GRAPHIC 112441
4 a2017investorpresentatio002.jpg GRAPHIC 234816
5 a2017investorpresentatio003.jpg GRAPHIC 146046
6 a2017investorpresentatio004.jpg GRAPHIC 137417
7 a2017investorpresentatio005.jpg GRAPHIC 111222
8 a2017investorpresentatio006.jpg GRAPHIC 113485
9 a2017investorpresentatio007.jpg GRAPHIC 119151
10 a2017investorpresentatio008.jpg GRAPHIC 166183
11 a2017investorpresentatio009.jpg GRAPHIC 187394
12 a2017investorpresentatio010.jpg GRAPHIC 83378
13 a2017investorpresentatio011.jpg GRAPHIC 101623
14 a2017investorpresentatio012.jpg GRAPHIC 105649
15 a2017investorpresentatio013.jpg GRAPHIC 125346
16 a2017investorpresentatio014.jpg GRAPHIC 125755
17 a2017investorpresentatio015.jpg GRAPHIC 137965
18 a2017investorpresentatio016.jpg GRAPHIC 122197
19 a2017investorpresentatio017.jpg GRAPHIC 77928
20 a2017investorpresentatio018.jpg GRAPHIC 85914
21 a2017investorpresentatio019.jpg GRAPHIC 78807
22 a2017investorpresentatio020.jpg GRAPHIC 118270
23 a2017investorpresentatio021.jpg GRAPHIC 100279
24 a2017investorpresentatio022.jpg GRAPHIC 129810
25 a2017investorpresentatio023.jpg GRAPHIC 87339
26 a2017investorpresentatio024.jpg GRAPHIC 87091
27 a2017investorpresentatio025.jpg GRAPHIC 149246
28 a2017investorpresentatio026.jpg GRAPHIC 131044
29 a2017investorpresentatio027.jpg GRAPHIC 108901
30 a2017investorpresentatio028.jpg GRAPHIC 93109
31 a2017investorpresentatio029.jpg GRAPHIC 96069
32 a2017investorpresentatio030.jpg GRAPHIC 123062
33 a2017investorpresentatio031.jpg GRAPHIC 92813
34 a2017investorpresentatio032.jpg GRAPHIC 92638
35 a2017investorpresentatio033.jpg GRAPHIC 51302
36 a2017investorpresentatio034.jpg GRAPHIC 80501
37 a2017investorpresentatio035.jpg GRAPHIC 100862
38 a2017investorpresentatio036.jpg GRAPHIC 77707
39 a2017investorpresentatio037.jpg GRAPHIC 97445
40 a2017investorpresentatio038.jpg GRAPHIC 89413
41 a2017investorpresentatio039.jpg GRAPHIC 69980
42 a2017investorpresentatio040.jpg GRAPHIC 179511
43 a2017investorpresentatio041.jpg GRAPHIC 105794
44 a2017investorpresentatio042.jpg GRAPHIC 132762
45 a2017investorpresentatio043.jpg GRAPHIC 127711
46 a2017investorpresentatio044.jpg GRAPHIC 77110
47 a2017investorpresentatio045.jpg GRAPHIC 126563
  Complete submission text file 0001561743-17-000002.txt   7048197
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 17512908
SIC: 2834 Pharmaceutical Preparations